The purpose of this study was to identify four non-cancer populations that might benefit from a palliative approach; and describe and compare the prevalence and patterns of dignity related distress across these diverse clinical populations.
Outpatient clinics, inpatient facilities or personal care homes, located in Winnipeg, Manitoba and Edmonton, Alberta, Canada.
Patients with advanced Amyotrophic Lateral Sclerosis (ALS), Chronic Obstructive Pulmonary Disease (COPD), End Stage Renal Disease (ESRD); and the institutionalized alert frail elderly.
Main Outcome Measure
In addition to standardized measures of physical, psychological and spiritual aspects of patient experience, the Patient Dignity Inventory (PDI).
Between February 2009 and December 2012, 404 participants were recruited (ALS, 101; COPD, 100; ESRD, 101; and frail elderly, 102). Depending on group designation, 35% to 58% died within one year of taking part in the study. While moderate to severe loss of sense of dignity did not differ significantly across the four study populations (4–11%), the number of PDI items reported as problematic was significantly different i.e. ALS 6.2 (5.2), COPD 5.6 (5.9), frail elderly 3.0 (4.4) and ESRD 2.3 (3.9) [p < .0001]. Each of the study populations also revealed unique and distinct patterns of physical, psychological and existential distress.
People with ALS, COPD, ESRD and the frail elderly face unique challenges as they move towards the end of life. Knowing the intricacies of distress and how they differ across these groups broadens our understanding of end-of-life experience within non-cancer populations and how best to meet their palliative care needs.
Citation: Chochinov HM, Johnston W, McClement SE, Hack TF, Dufault B, Enns M, et al. (2016) Dignity and Distress towards the End of Life across Four Non-Cancer Populations. PLoS ONE 11(1): e0147607. https://doi.org/10.1371/journal.pone.0147607
Editor: Terence J. Quinn, University of Glasgow, UNITED KINGDOM
Received: April 17, 2015; Accepted: January 6, 2016; Published: January 25, 2016
Copyright: © 2016 Chochinov et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Ethical approval precludes the data being used for another purpose or being provided to researchers who have not signed the appropriate confidentiality agreement. These restrictions are as per the Bannatyne Biomedical Research Ethics Board, University of Manitoba (firstname.lastname@example.org). In accordance with ethical approval, all results are in aggregated form to maintain confidentiality and privacy. The data is held at the Manitoba Palliative Care Research Unit, Winnipeg, Canada.
Funding: Funding provided by Canadian Institutes for Health Research, http://www.cihr-irsc.gc.ca, Grant # 93640. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Despite their physical, psychological and existential suffering, patients with non-malignant conditions such as ALS, ESRD, and COPD tend to be underserved by palliative care[1–7]. Such is also the case for the institutionalized elderly, for whom palliative care services and supports are frequently lacking.The elderly do not usually think of themselves as terminally ill ; while patients with life limiting illnesses often manage to disregard the reality of their terminal circumstances[9–11]. Relative to cancer, people with non-malignant conditions tend to have less prognostic certainty. While the combination of uncertainty and denial may curtail the application of palliative approaches, so too does lack of familiarity with the burden of suffering people face as they move closer to death.
The lived experience of end stage cancer has been well documented, [12–14] as have the physical, psychological, existential and spiritual sources of distress that can undermine dignity in patients with advanced cancer. The latter derives from a study of various factors influencing sense of dignity in dying patients; culminating in an empirical model of dignity in the terminally ill . This model is unique, in that it provides therapeutic guidance and insight into how dignity can be maintained or undermined as patients draw closer to death. This model forms the basis of dignity conserving palliative care , given that each of the model themes and sub-themes implicate issues that clinicians must be aware of and attentive to, in order to mitigate patient suffering and distress. The model also informed the development a psychometric coined the Patient Dignity Inventory (PDI). The PDI is a novel screening instrument tapping into multiple sources of distress salient for patients with limited life expectancies. The PDI has been validated in multiple languages and applied in various palliative care settings and studies worldwide [18–24]. One national study reported that amongst patients with varying stages of cancer, the PDI readily helped clinicians identify dignity related distress. In 76% of instances, it disclosed information clinicians were previously unaware of and enabled them to provide more timely and targeted therapeutic responses to patients’ concerns. To date, however, this research has largely been confined to cancer. The objective of this study was to identify four non-cancer populations that might benefit from a palliative approach and, using the PDI, describe and compare the landscape of dignity related distress for each of these diverse groups.
A prospective multi-site approach was used to examine physical, psychological, existential and spiritual issues facing patients with advanced ALS, COPD, ESRD; and the institutionalized alert frail elderly (subsequently referred to as the frail elderly). This report describes cross-sectional patient/resident data and differences across these diverse groups. Participating centres included Winnipeg, Canada (Health Sciences Centre, St. Boniface General Hospital, Winnipeg Regional Health Authority) and Edmonton, Canada (University of Alberta Hospital, Alberta Health Services, Covenant Health, and CapitalCare). The study protocol was approved by ethics boards at the University of Manitoba and the University of Alberta.
Clinical staff in outpatient clinics, inpatient facilities or personal care homes identified potential participants according to study entry criteria. Study participants were within one of the four clinical populations of interest, able to read and understand English, and competent (based on clinical consensus). Eligibility criteria within each of the four study populations were designed to identify people whose current clinical status suggested imminently life-limiting circumstances, hence most likely to benefit from a palliative care approach. These criteria were also designed to distinguish groups from one another; i.e. participants were only able to meet eligibility criteria for one group. Patients with ALS were considered eligible if they had: 1) a medically confirmed diagnosis of their condition; 2) mobility limitations, dysphagia, dyspnea or speech problems that interfered with their social or occupational functioning; and 3) were between 18 and 80 years of age. Patients with ESRD were eligible if they were: 1) receiving dialysis for 3 or more months; and 2) between 65 and 80 years of age. Eligibility criteria for patients with COPD included: 1) having stage 4 disease, based on Global Initiative for Chronic Obstructive Lung Disease GOLD classification; and 2) being between 65 and 80 years of age. The frail elderly were defined as: 1) being over 80 years of age; 2) residing in a personal care home (PCH); and 3) requiring assistance with two or more basic activities of daily living (bathing, dressing, toileting, grooming, feeding, ambulation); and 4) having a Cognitive Performance Scale (CPS) of zero to three (i.e. none to mild cognitive decline) .
All patients or residents meeting eligibility criteria were asked permission by the clinical staff to have their name released to the study nurse or research assistant, who then confirmed eligibility and obtained written consent. Basic demographic information was gathered, along with information regarding their current health status. Participants were then administered questionnaires by the research nurse or assistant–either in the hospital, outpatient unit or personal care home—assessing their existential distress (Structured Interview of Symptoms and Concerns [SISC]); hope (Herth Hope Index [HHI] ); spirituality (Spiritual Survey ); physical symptoms (Revised Edmonton Symptom Assessment Scale [ESAS-R] ); comorbidities (Charlson Comorbidity Index ); activities of daily living (The Katz Index of Daily Basic Living ); depression (using the depression subscale of the Hospital Anxiety Depression Scale [HADS] ); and social support (The Multidimensional Scale of Perceived Social Support [MSPSS] ).
Participants were also administered the Patient Dignity Inventory (PDI), a 25-item instrument tapping into a broad spectrum of physical, psychological and existential issues, with each item ranging from 1 (not a problem) to 5 (an overwhelming problem) [a score of ≥3 denotes a problem]. The protocol was very well tolerated across all study groups; (details regarding the latter, including attitudes towards being research participants, will be reported in a separate manuscript). In preparing to launch the study and to elicit feedback regarding the applicability of this instrument to non-cancer populations, the PDI was administered to 62 participants (13 with ALS; 21 with ESRD; 16 with COPD; and 12 frail elderly). On the basis of this pilot data, two items that made reference to sickness were revised to read health status, given that the frail elderly did not necessarily see themselves as sick.
One hundred patients were recruited for each of four population groups. Using estimation procedures established by Cohen , this sample size ensures an 80 per cent power of detecting a small to medium-sized difference between the four groups when testing is carried out at the conventional 0.05 level. All analyses were conducted using SAS Version 9.3 (SAS Institute, Cary NC). Descriptive statistics (mean, standard deviation, and percentages, as appropriate) were calculated. The proportion of individuals experiencing a particular problem, defined as a PDI item rating of ≥ 3, was compared between groups using the Chi-squared test or the Fisher’s exact test. The total number of PDI problems was compared between groups using ANOVA models (PROC MIXED in SAS) generalized to allow heterogeneous group variances. The Kruskal-Wallis test was used to compare the distributions of ESAS items, Spirituality Survey, HADS, MSPSS, and the HHI between patient groups, as well as between those reporting intact (SISC Dignity Rating < 3) versus fractured sense of dignity (SISC Dignity Rating ≥ 3). Unless specifically stated, all statistical tests were carried out on a two-tailed basis, using 0.05 alpha level of significance.
Study recruitment took place between February 2009 and December 2012. Date of death was tracked until September 2013. Of 663 eligible people approached, 249 declined. Reasons for non-participation included not interested (222), too busy (14), did not respond to an invitation to take part (11), or the family said no (2). Of the remaining 404 participants (61%), 101 had ALS, 100 COPD, 101 ESRD and 102 were frail elderly (Table 1). While there was some variation within groups, the total sample was evenly divided between the two primary recruitment sites (see Table 1). Fifty-two percent of the sample was male. Average ages were 63.9 (12.0) years for ALS, 72.3 (4.8) years for COPD, 72.3 (4.4) years for ERSD and 88.2 (5.0) years for the frail elderly. By September 2013, 45% of participants had died (ALS, 58% [1.13 (.87) year survival]; frail elderly, 42% [1.49 (.95)]; ESRD, 41% [1.6 (.93)]; and COPD, 35% [1.10 (.87)]).
Between 84–90% of study participants in the ALS, COPD and ESRD cohorts were living at home, while all of the frail elderly subjects were living in residential care. Within the ALS, COPD and ESRD cohorts, 51.0–68.3% were married or common-law; however, only 13.7% of the frail elderly were married or common-law (the majority [71.6%] were widowed). Similarly, while primary social support from spouse/partner in other groups ranged between 47.5–67.0%, only 9.8% of the frail elderly identified spouse/partner as their primary support, with children fulfilling that role in 66.8% of instances. The perceived level of social support, as measured by the MSPSS, ranged from least supported, the frail elderly, followed by ESRD, COPD, to the most supported, ALS (p < .0001) (Table 2). Relative to other groups, the frail elderly felt less supported by family (p = .005), friends (p < .0001) or a significant other (p < .0009).
Physical Disability and Symptom Burden
There were no significant differences across groups on measures of pain, nausea, drowsiness, constipation and difficulty thinking (Table 2). Fatigue and weakness were most pronounced in ALS (p<0.001), as were lack of appetite (p < .009) and activity (p < .0001). Fatigue in COPD appeared comparable to ALS, with COPD patients most likely to experience shortness of breath (p < .001) and dizziness (p < .04). Patients with ESRD reported the most trouble sleeping (p < .0001), diarrhea (p < .02) and the highest number of co-morbidities (7.8, [2.0]; p < .0001). The frail elderly reported the most dependencies (3.3, [1.5]; p < .0001).
Existential, Spiritual and Psychological Distress
Mean ESAS-R ratings on will to live and sense of well-being were comparable between groups, as were measures of spiritual beliefs (Table 2). Based on SISC measures (Table 3), the four groups did not differ with respect to sense of suffering (5.9–12.8%), hopelessness (4.0–8.7%) or general dissatisfaction with life (2.0–5.2%). The only group to report moderate to extreme suicidal ideation was ESRD (5.9%: p = .0005).(Table 3). The highest rate of anxiety was reported in patients with COPD, as measured by the ESAS-R (Table 2) and the PDI (Table 4). Depression as measured by the HADS (Table 2) and the PDI (Table 4), appeared to be significantly higher in COPD and ALS relative to the other groups. The frail elderly reported the highest prevalence of moderate to extreme desire for death (7.9%; p = .04) (Table 3); and the lowest level of hope (based on the HHI; Table 2 [p = .008]).
Dignity related distress
While there were no significant differences across the four groups on global ratings of moderate to extreme loss of dignity (SISC item score > 3; Table 3)—ALS, 11.0%; frail elderly, 6.0%; and COPD and ESRD, both 4.0%—participants varied significantly on the mean number of PDI items rated as problematic: ALS 6.2 (5.2), COPD 5.6 (5.9), frail elderly 3.0 (4.4) and ESRD 2.3 (3.9) [p < .0001] (Table 2). Patients with ALS were significantly more likely than other groups to identify the following PDI items as problematic: not being able to continue my usual routines (49.5%); not being able to carry out tasks associated with daily living (45.5%); feeling a burden to others (42.6%); worrying about my future (41.6%); not being able to carry out important roles (42.0%); feeling like I am no longer who I was (41.5%); feeling that I don’t have control over my life (37.6%); feelings of unfinished business (32.7%); feeling my health can care needs have reduced my privacy (26.7%); not feeling worthwhile or valued (24.7%); and feeling how I look to others has changed significantly (22.8%) [p < .01-.0001]. Relative to the other groups, patients with COPD were most likely to rate the following PDI items as problematic: experiencing physically distressing symptoms (60.6%), uncertain about my health and health care (44.4%), feeling anxious (30.0%) or depressed (23.0% in COPD) (p < .001-.0001). Relative to other groups, frail elderly patients were most likely to identify ‘not being able to attend to my bodily functions independently’ as problematic (31.7%) [p < .0001]. ESRD did not rate significantly highest on any single PDI item (Table 4).
There were differences between participants whose dignity was intact and those whose dignity was fractured (Tables 2–4). Those whose dignity was intact reported fewer PDI items as problematic (3.9 [4.9]) relative to those whose dignity was fractured (9.2 [5.6], p < .0001). While study group affiliation, gender, marital status and age did not differentiate between these two groups, PDI items that most significantly differentiated these groups (p < .0001) included worrying about the future, feeling like I am no longer who I was, feelings of unfinished business, feeling a burden to others, not having control over my life, feeling that my health and care needs have reduced my privacy and not being able to accept the way things are (Table 4). Fractured dignity was also highly affiliated with intensity of suffering (p < .0001), hopelessness (p < .0001) desire for death (p = .0002) and decreased general life satisfaction and fulfillment (p < .0001)[Table 3]. Besides these dominantly existential issues, psychological symptoms such as anxiety (based on the PDI [p = .007] and the ESAS-R [p = .003]) and depression (based on the HADS [p = .002] and PDI [p = .004]) differentiated those with intact dignity from those whose dignity was fractured; various physical parameters, to a lesser extent, differentiated these two groups. Those reporting fractured dignity reported more dependencies (p = .002), fatigue (p = .001), constipation (p = .0002); weakness (p = .001) and poorer appetite (p = .0006) [Table 2].
This study is the first to describe and compare the landscape of dignity related distress across several non-cancer populations including advanced COPD, ALS, ESRD, and the frail institutionalized elderly. While overall loss of dignity did not differ significantly across these study populations and were comparable to those previously reported in end-stage cancer , the patterns of distress in each of these groups revealed distinct and important insights. Patients with ALS reported more dignity related distress such as not being able to fulfill important roles, tasks or daily routines; feeling like a burden to others, feeling a loss of control and no longer feeling worthwhile or valued. They experienced more weakness and fatigue, and were more likely to feel depressed, and to worry about the future. Their ratings of shortness of breath were second only to COPD, which is noteworthy, given the association in ALS between fear of suffocation and requests for euthanasia or physician-assisted death .
COPD patients rated on average 5.7 PDI items as problematic, identical to the number reported by hospice patients with advanced cancer .These patients were most likely to experience physically distressing symptoms and predictably, the highest intensity of shortness of breath. Consistent with clinical experience and the published literature , their intensity and frequency of anxiety were highest. The etiology of shortness of breath in COPD is thought be physiological and affective, with affected neurophysiological mechanisms causing distressing sensations, contributing to panic and anxiety ; and anxiety and depression intensifying sensations of shortness of breath .Low desire for death and the absence of suicidal ideation suggests that a slow insidious progression of illness allows for gradual adaptation to physical symptoms, disability and mounting losses. It also appears that limited prognostic awareness or prognostic disavowal form part of the psychological landscape, even for patients with advanced COPD [42, 43].Over the course of the study, patients with COPD displayed the lowest mortality (35%), but were most likely to express uncertainty about their health and health care. This is consistent with prior studies and prognostic models , underscoring the observation that patients with COPD have a less predictable terminal course, posing a barrier to the earlier initiation of palliative care .
While patients with ESRD did not report any PDI items in excess of the other study populations, they were the only group that included patients with moderate to severe suicidal ideation. These patients also reported the highest number of comorbidities and prominent symptom burden. Paucity of depression or loss of hope suggests that suicidal ideation may be driven by physical, more so than psychological factors. This is consistent with previous studies, which indicate that patients contemplating dialysis discontinuation do not seem to be influenced by major depression .The endorsement of suicidal ideation for this group may be a proxy for contemplating dialysis discontinuation .Decisions to withdraw dialysis now precede one in four deaths of patients who have end-stage renal disease .
The frail elderly are unique from the other study groups in several ways. Rather than being defined on the basis of illness, they were defined on the basis of age and frailty. While the elderly are not typically described as ‘terminally ill’, 42% of them died over the course of the study. Relative to the other groups, they are the most isolated and report the lowest social support from family, friends or a significant other. They report feeling the least hope, in the absence of significant worry about the future. The measure of hope (HHI) was based on a definition developed by Dufault and Martocchio , who described hope as a multidimensional construct that is characterized by confident yet uncertain expectations of achieving good, which is realistically possible and personally significant. This suggests that the elderly do not see their future holding such potential. Along with reporting the highest desire for death, in the absence of suicidal ideation or disproportionate psychological distress, a picture emerges of elderly residents being at relative ease compared to other study populations. They are not particularly worried or frightened of the future; with an endorsement of desire for death perhaps indicative of a readiness to die. This is consistent with most evidence that concludes fear of death tends to be greater among younger age groups and declines with increasing age [50–53].
While study group affiliation did not differentiate participants whose dignity was most likely to be compromised, various existential, psychological and to a seemingly lesser extent physical issues, distinguished those whose dignity was and was not intact. In other words, the intricacies of dignity seem best understood, not so much according to the specific condition moving someone towards death, but the constellation of issues imposed by said condition. Consistent with previous studies [15,17,54,55], losing dignity is affiliated with an assault on personhood, and feeling a diminished sense of worth or value; a burden to others; not feeling in control of one’s life; having unfinished business; worrying about the future, while expressing dissatisfaction with the past—along with constitutional symptoms, such as fatigue, constipation and weakness, which can further undermine autonomy and heighten physical dependency.
The primary limitation of this study is that it knowingly chose to examine four populations at a very specific point in time. Each group was identified according to criteria suggesting relative proximity to death and hence, the appropriateness of a palliative care approach. The study was designed to differentiate groups from one another, making them as mutually exclusive as possible. As such, all frail elderly participants were competent (a minority of residents in personal care homes) and older than 80 years of age; patients with ALS were adults up to 80 years of age; and patients with COPD or ESRD were 65 to 80 years of age, and thus more likely to have a more imminent terminal course. While these specific criteria may somewhat limit the generalizability of our findings, designing the study in this fashion was necessary to examine differences across these four non-cancer populations.
The PDI provides a novel way to examine the complexities of patient experience in these non-cancer populations. These populations can certainly be described as nearing death, given that 35–58% of them, depending on group affiliation, died during the course of the study. These deaths took place over a protracted period of months, hence supporting the rational for earlier integration of palliative care. Despite levels of distress comparable to patients with end-stage cancer, palliative approaches tend to be underutilized for non-malignant conditions or not offered at all. Applying the PDI across these four populations reveals unique constellations of symptoms and issues along distinct pathways leading to death. Knowing the intricacies of distress marking these pathways will broaden our understanding of end-of-life experience for these non-cancer populations and how best to meet their palliative care needs.
Conceived and designed the experiments: HMC WJ SEM TFH BD ME GT MH RWD CR SD JZ DM DS HCE MSK. Performed the experiments: HMC WJ SEM TFH ME GT MH RWD CR SD JZ DM DS. Analyzed the data: HMC WJ SEM TFH BD ME GT MH RWD CR SD JZ DM DS HCE MSK. Contributed reagents/materials/analysis tools: HMC WJ SEM TFH BD ME GT MH RWD CR SD JZ DM DS HCE MSK. Wrote the paper: HMC WJ SEM TFH BD ME GT MH RWD CR SD JZ DM DS HCE MSK.
- 1. Fitzsimons D, Mullan D, Wilson JS, Conway B, Corcoran B, Dempster M, et al. The challenge of patients’ unmet palliative care needs in the final stages of chronic illness. Palliat Med. 2007 Jun;21(4):313–22. pmid:17656408
- 2. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006 Jan;31(1):58–69. pmid:16442483
- 3. McIlfatrick S. Assessing palliative care needs: views of patients, informal carers and healthcare professionals. J Adv Nurs. 2007 Jan;57(1):77–86. pmid:17184376
- 4. Skilbeck JK, Payne S. End of life care: a discursive analysis of specialist palliative care nursing. J Adv Nurs. 2005 Aug;51(4):325–34. pmid:16086801
- 5. Luddington L, Cox S, Higginson I, Livesley B. The need for palliative care for patients with non-cancer diseases: a review of the evidence. Int J Palliat Nurs. 2001 May;7(5):221–6. pmid:12148972
- 6. Reynolds K, Henderson M, Schulman A, Hanson LC. Needs of the dying in nursing homes. J Palliat Med. 2002 Dec;5(6):895–901. pmid:12685536
- 7. Murray AM, Arko C, Chen S- C, Gilbertson DT, Moss AH. Use of hospice in the United States dialysis population. Clin J Am Soc Nephrol CJASN. 2006 Nov;1(6):1248–55. pmid:17699355
- 8. McVey P, McKenzie H, White K. A community-of-care: the integration of a palliative approach within residential aged care facilities in Australia. Health Soc Care Community. 2014 Mar;22(2):197–209. pmid:24200015
- 9. Davison SN, Jhangri GS, Koffman J. Knowledge of and attitudes towards palliative care and hospice services among patients with advanced chronic kidney disease. BMJ Support Palliat Care. 2014 Jun 10;
- 10. Davison SN. End-of-life care preferences and needs: perceptions of patients with chronic kidney disease. Clin J Am Soc Nephrol CJASN. 2010 Feb;5(2):195–204. pmid:20089488
- 11. Gott M, Gardiner C, Small N, Payne S, Seamark D, Barnes S, et al. Barriers to advance care planning in chronic obstructive pulmonary disease. Palliat Med. 2009 Oct 1;23(7):642–8. pmid:19648222
- 12. McCarthy EP, Phillips RS, Zhong Z, Drews RE, Lynn J. Dying with cancer: patients’ function, symptoms, and care preferences as death approaches. J Am Geriatr Soc. 2000 May;48(5 Suppl):S110–21. pmid:10809464
- 13. Benzein E, Norberg A, Saveman B-I. The meaning of the lived experience of hope in patients with cancer in palliative home care. Palliat Med. 2001 Mar 1;15(2):117–26. pmid:11301662
- 14. Tamura K, Kikui K, Watanabe M. Caring for the spiritual pain of patients with advanced cancer: A phenomenological approach to the lived experience. Palliat Support Care. 2006 Jun;4(02):189–96.
- 15. Chochinov HM, Hack T, McClement S, Kristjanson L, Harlos M. Dignity in the terminally ill: a developing empirical model. Soc Sci Med 1982. 2002 Feb;54(3):433–43.
- 16. Chochinov HM. Dignity-conserving care-a new model for palliative care: helping the patient feel valued. JAMA J Am Med Assoc. 2002 May 1;287(17):2253–60.
- 17. Chochinov HM, Hassard T, McClement S, Hack T, Kristjanson LJ, Harlos M, et al. The patient dignity inventory: a novel way of measuring dignity-related distress in palliative care. J Pain Symptom Manage. 2008 Dec;36(6):559–71. pmid:18579340
- 18. Albers G, de Vet HCW, Pasman HRW, Deliens L, Onwuteaka-Philipsen BD. Personal dignity in the terminally ill from the perspective of caregivers: a survey among trained volunteers and physicians. J Palliat Med. 2013 Sep;16(9):1108–14. pmid:23941564
- 19. Hall S, Goddard C, Martin P, Opio D, Speck P. Exploring the impact of dignity therapy on distressed patients with advanced cancer: three case studies. Psychooncology. 2013 Aug;22(8):1748–52. pmid:23055454
- 20. Hall S, Goddard C, Opio D, Speck P, Higginson IJ. Feasibility, acceptability and potential effectiveness of Dignity Therapy for older people in care homes: a phase II randomized controlled trial of a brief palliative care psychotherapy. Palliat Med. 2012 Jul;26(5):703–12. pmid:21859743
- 21. Johnston B, Östlund U, Brown H. Evaluation of the Dignity Care Pathway for community nurses caring for people at the end of life. Int J Palliat Nurs. 2012 Oct;18(10):483–9. pmid:23123951
- 22. Oechsle K, Wais MC, Vehling S, Bokemeyer C, Mehnert A. Relationship between symptom burden, distress, and sense of dignity in terminally ill cancer patients. J Pain Symptom Manage. 2014 Sep;48(3):313–21. pmid:24766742
- 23. Sautier LP, Vehling S, Mehnert A. Assessment of Patients’ Dignity in Cancer Care: Preliminary Psychometrics of the German Version of the Patient Dignity Inventory (PDI-G). J Pain Symptom Manage. 2014 Jan;47(1):181–8. pmid:23830532
- 24. Vehling S, Mehnert A. Symptom burden, loss of dignity, and demoralization in patients with cancer: a mediation model. Psychooncology. 2014 Mar;23(3):283–90. pmid:24123321
- 25. Chochinov HM, McClement SE, Hack TF, McKeen NA, Rach AM, Gagnon P, et al. The Patient Dignity Inventory: applications in the oncology setting. J Palliat Med. 2012 Sep;15(9):998–1005. pmid:22946576
- 26. Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease [Internet]. 2014. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jun11.pdf
- 27. Morris JN, Fries BE, Mehr DR, Hawes C, Phillips C, Mor V, et al. MDS Cognitive Performance Scale. J Gerontol. 1994 Jul 1;49(4):M174–82. pmid:8014392
- 28. Wilson KG, Graham ID, Viola RA, Chater S, de Faye BJ, Weaver LA, et al. Structured interview assessment of symptoms and concerns in palliative care. Can J Psychiatry Rev Can Psychiatr. 2004 Jun;49(6):350–8.
- 29. Herth K. Abbreviated instrument to measure hope: development and psychometric evaluation. J Adv Nurs. 1992 Oct 1;17(10):1251–9. pmid:1430629
- 30. Kimmel PL, Emont SL, Newmann JM, Danko H, Moss AH. ESRD patient quality of life: symptoms, spiritual beliefs, psychosocial factors, and ethnicity. Am J Kidney Dis Off J Natl Kidney Found. 2003 Oct;42(4):713–21.
- 31. Watanabe SM, Nekolaichuk C, Beaumont C, Johnson L, Myers J, Strasser F. A Multicenter Study Comparing Two Numerical Versions of the Edmonton Symptom Assessment System in Palliative Care Patients. J Pain Symptom Manage. 2011 Feb;41(2):456–68. pmid:20832987
- 32. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994 Nov;47(11):1245–51. pmid:7722560
- 33. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged: The index of adl: a standardized measure of biological and psychosocial function. JAMA. 1963 Sep 21;185(12):914–9.
- 34. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–70. pmid:6880820
- 35. Zimet GD, Dahlem NW, Zimet SG, Farley GK. The Multidimensional Scale of Perceived Social Support. J Pers Assess. 1988 Mar 1;52(1):30–41.
- 36. Cohen J. Statistical Power Analysis for the Behavioral Sciences. L. Erlbaum Associates; 1988. 594 p.
- 37. Chochinov HM, Hassard T, McClement S, Hack T, Kristjanson LJ, Harlos M, et al. The landscape of distress in the terminally ill. J Pain Symptom Manage. 2009 Nov;38(5):641–9. pmid:19713069
- 38. Maessen M, Veldink JH, van den Berg LH, Schouten HJ, van der Wal G, Onwuteaka-Philipsen BD. Requests for euthanasia: origin of suffering in ALS, heart failure, and cancer patients. J Neurol. 2010 Jul;257(7):1192–8. pmid:20148336
- 39. von Leupoldt A, Kenn K. The psychology of chronic obstructive pulmonary disease. Curr Opin Psychiatry. 2013 Sep;26(5):458–63. pmid:23867658
- 40. O’Donnell DE, Banzett RB, Carrieri-Kohlman V, Casaburi R, Davenport PW, Gandevia SC, et al. Pathophysiology of Dyspnea in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc. 2007 May 1;4(2):145–68. pmid:17494725
- 41. Neuman Å, Gunnbjörnsdottir M, Tunsäter A, Nyström L, Franklin KA, Norrman E, et al. Dyspnea in relation to symptoms of anxiety and depression: A prospective population study. Respir Med. 2006 Oct;100(10):1843–9. pmid:16516455
- 42. Elkington H, White P, Addington-Hall J, Higgs R, Edmonds P. The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat Med. 2005 Sep 1;19(6):485–91. pmid:16218161
- 43. Edmonds P, Karlsen S, Khan S, Addington-Hall J. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med. 2001 Jul;15(4):287–95. pmid:12054146
- 44. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-`mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004 Mar 4;350(10):1005–12. pmid:14999112
- 45. Pinnock H, Kendall M, Murray SA, Worth A, Levack P, Porter M, et al. Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study. BMJ. 2011;342:d142. pmid:21262897
- 46. Cohen LM, Dobscha SK, Hails KC, Pekow PS, Chochinov HM. Depression and suicidal ideation in patients who discontinue the life-support treatment of dialysis. Psychosom Med. 2002 Dec;64(6):889–96. pmid:12461194
- 47. Cohen LM, Bostwick JM, Mirot A, Garb J, Braden G, Germain M. A psychiatric perspective of dialysis discontinuation. J Palliat Med. 2007 Dec;10(6):1262–5. pmid:18095804
- 48. Cohen LM, Germain MJ, Poppel DM. Practical considerations in dialysis withdrawal: “to have that option is a blessing.” JAMA. 2003 Apr 23;289(16):2113–9. pmid:12709469
- 49. Dufault K, Martocchio BC. Symposium on compassionate care and the dying experience. Hope: its spheres and dimensions. Nurs Clin North Am. 1985 Jun;20(2):379–91. pmid:3846980
- 50. Bengtson VL, Cuellar JB, Ragan PK. Stratum contrasts and similarities in attitudes toward death. J Gerontol. 1977 Jan;32(1):76–88. pmid:830739
- 51. Gesser G, Wong PTP, Reker GT. Death Attitudes across the Life-Span: The Development and Validation of the Death Attitude Profile (DAP). OMEGA—J Death Dying. 1988 Mar 1;18(2):113–28.
- 52. Neimeyer RA, Van Brunt D. Death anxiety. In: Wass H, Neimeyer RA, editors. Dying: Facing the facts. 3rd ed. Washington (DC): Taylor & Francis; 1995.
- 53. Thorson JA, Powell FC. Death anxiety in younger and older adults. In: Tomer A, editor. Death attitudes and the older adult Theories, concepts, and applications. Philadelphia, PA: Taylor & Francis; 2000. p. p. 123–36.
- 54. Thompson GN, Chochinov HM. Dignity-based approaches in the care of terminally ill patients. Curr Opin Support Palliat Care. 2008 Mar;2(1):49–53. pmid:18685395
- 55. Chochinov HM. Dignity and the eye of the beholder. J Clin Oncol Off J Am Soc Clin Oncol. 2004 Apr 1;22(7):1336–40.